about
HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, IranOccult hepatitis B virus infection in hemodialysis patients: a concept for consideration.Viral Hepatitis and HIV Infection in Hemodialysis Patients.Serum profile of T helper 1 and T helper 2 cytokines in hepatitis C virus infected patientsNo correlation between interleukin-10 gene promoter polymorphisms and hepatitis B virus infection outcome.Detection of hepatitis G virus envelope protein E2 antibody in blood donors.Hepatitis G virus exposure in dialysis patients.Hepatitis G virus exposure in dialysis staff.Risk factors for human brucellosis in Iran: a case-control study.Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy.Viral hepatitis and HIV infection among injection drug users in a central Iranian City.Frequency and associated factors of proteinuria in Iranian HIV-positive patients.Importance of isolated anti-hbc in detection of occult hepatitis B virus infection in hemodialysis patients.Persistence of antibody to hepatitis B surface antigen among vaccinated children in a low hepatitis B virus endemic area.Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma.Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection.The role of human papillomavirus infection in prostate carcinoma.Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients.Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population.Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donorsAssessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patientsSurface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infectionEfficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patientsPersistence of Hepatitis B Vaccine Immunity in Hemodialysis Patients
P50
Q33784758-A169A767-81BF-4C7C-A0EA-E8B009D75935Q38027897-AED5F908-7F80-4955-815B-7BD29D9FDA71Q41763982-CC3E4122-75A4-41F1-8806-D3A24016D2E5Q41866166-FC033B43-2B7B-41DD-A6E1-D08E7717AB70Q42252086-6A834682-90D1-4673-8BC8-734AA6781ED7Q43039269-F560F2B9-A53A-4503-B253-8BF494FD85E4Q43040422-5F33805E-BC3C-45A3-9F3D-20E59F3767D4Q43040575-DC661453-9321-4701-BA1A-06CE22FEBADEQ43222968-730C8741-B2EE-4B0B-8DE8-5E5CBE9D539CQ43503742-B0CA67BA-1E06-4BC7-99AF-1DEC95B8BD2FQ44579586-CD4369DD-2D45-4D9B-B2C9-6C8FD6D424D2Q45047158-7919B126-3E54-4E7A-9BA5-B5A0DD2D86DAQ45349458-810B64D0-18C3-432F-ACAE-D9A2E81F8CC7Q45363795-12DC196D-7059-41FF-B8AA-87CC8BC1310FQ45382290-9AD892EC-6191-420F-81AF-E21603087C1BQ45385144-1633C4A6-21A1-42D2-829D-13D119AE6BE9Q45387415-1488D55A-FA8C-4503-A939-AEB5F43C8E3FQ45390349-894E6D30-8351-42DA-8963-7081BF1790DAQ45391727-B00F4661-D7BE-47DA-8A93-592A62D01C29Q45399558-321227ED-072B-4A5F-BEC2-91B439F7EF25Q46785961-FB8EC4B6-46B6-42C1-9893-CE9F423615DEQ51760902-595E0CC3-6A73-4C42-8DB0-D5072BF53A43Q51802180-BB83C11F-DD3D-49AD-82AD-40E0CB7AB822Q59745015-05834191-C003-4BAA-86D2-A7A1700E26FAQ59745069-BE9FD9D9-ED30-4D4F-8182-6E0CCA835A37Q59745087-6C025DD0-B89F-4A77-9540-EF3A8188A8B8Q59745105-425213CF-BB9D-4F78-AE99-888AD7ED6B40Q59745139-E57EC683-3870-4EFC-AE75-DCE349F67241
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Amitis Ramezani
@ast
Amitis Ramezani
@en
Amitis Ramezani
@es
Amitis Ramezani
@nl
type
label
Amitis Ramezani
@ast
Amitis Ramezani
@en
Amitis Ramezani
@es
Amitis Ramezani
@nl
prefLabel
Amitis Ramezani
@ast
Amitis Ramezani
@en
Amitis Ramezani
@es
Amitis Ramezani
@nl
P1053
E-8259-2012
P106
P1153
14051005100
P31
P3829
P496
0000-0003-3502-8524